Rafael Simó Canonge Institutions of which they are part Head of group Diabetes and Metabolism Vall Hebron Institut de Recerca Email Rafael Simó Canonge Email Institutions of which they are part Head of group Diabetes and Metabolism Vall Hebron Institut de Recerca
Projects Desarrollo de un tratamiento tópico (colirio) para la retinopatía diabética basado en la señalización de la vía del GLP-1 IP: Rafael Simó Canonge Collaborators: Cristina Hernández Pascual, Patricia Bogdanov Baruj Funding agency: Instituto de Salud Carlos III Funding: 177100 Reference: DTS15/00151 Duration: 01/01/2016 - 30/06/2018 DIALCAT: La Diabetis com accelerador de deteriorament cognitiu i malaltia d’ Alzheimer: abordatge integral d’un problema socio-sanitari de primera magnitud a Catalunya IP: Rafael Simó Canonge Collaborators: - Funding agency: Agència Competitivitat Empresa Catalana ACCIO Funding: 314055.38 Reference: COMRDI15-1-0024 Duration: 01/10/2016 - 07/03/2018 European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR). Neurodegeneration as an early event in the Pathogenesis of Diabetic Retinopathy: A multicentric, prospective, phase II-III, open randomized controlled trial to assess the e IP: Rafael Simó Canonge Collaborators: Miriam Izquierdo Sans Funding agency: Instituto de Salud Carlos III Funding: 30000 Reference: INT15/00126 Duration: 01/01/2016 - 31/12/2016 MOPEAD: Models Of Patient Engagement for Alzheimer’s Disease IP: Rafael Simó Canonge Collaborators: Cristina Hernández Pascual Funding agency: The Innovative Medicines Initiative Funding: 79887.5 Reference: MOPEAD_IMI2015 Duration: 01/09/2016 - 31/12/2019 Pagination First page « Previous page ‹ … Page 8 Page 9 Current page 10 Page 11 Page 12 … Next page › Last page »
